2 курс / Нормальная физиология / Ликвор_как_гуморальная_среда_организма_Пикалюк_В_С_,_Бессалова_Е

Yamashita et al. // Journal of Neural Transmission. – 2001. – Vol. 108, № 3. – P. 363–371.

339. Decreased plasma and cerebrospinal fluid content of neuroactive steroids in Parkinson's disease / F. Michele, P. Longone, E. Romeo et al. // Neurological Sciences. – 2003. – Vol. 24, № 3. – Р. 172–173.

340. Desiderio D. M. Mass spectrometric analysis of neuropeptidergic systems in the human pituitary and cerebrospinal fluid / D.М. Desiderio // J. Chromatogr В Biomed Sci Appl. – 1999. – Vol. 731, № 1. – P. 3–22.

341. Determination of free and total (free plus protein–bound) melatonin in plasmaКафедраand cerebrospinal fluid by high–performance liquid chromatography with fluorescence detection / V. Rizzo, C. Porta, M.

Moroni et al. // Journal of Chromatography B: Analytical Technologies in

the Biomedical and Life Sciences. – 2002. – Vol. 774, № 1. – Р. 17–24. 342.нормальнойDifferences in immune cell invasion into the cerebrospinal

fluid and brain parenchyma during cerebral infusion of interleukin–1β / B. Schoning, P. Elepfandt, N. Daberkow et al. // Neurol Sci. – 2002. –

Vol. 23. – P. 211–218.

P.14720 – 14725.

343. Directанатомииisolation of human central nervous system stem cells / N. Uchida, D.W. Buck, D. He et al. // PNAS. – 2000. – Vol. 97, № 26. –

344. Dixon W. Pituitary secretion / W.Dixon // J. Physiol. – 1923. – Vol. 57. – P. 129–138. КГМУ

345. Does neonatal cerebrospinal fluid absorption occur via arachnoid projections or extracranial lymphatics? / С. Papaiconomou, R. Bozanovic–Sosic, А. Zakharov, М. Johnston // Amer. J. Physiol. – 2002. – Vol. 283, № 4, ч. 2. – Р. R869–R876.

346. Dose–effects of recombinant human interleukin–6 on pituitary hormone secretion and energy expenditure / С. Tsigos, D.A. Papanicolaou, R. Defensor et al. // Neuroendocrinology. – 1997. – Vol. 66. – P. 54–62.

347. Dreder C.D. TNF immunoreactive innervation in the mouse brain / C.D. Dreder, С.В.Saper // Soc. Neirosci Abstr. – 1988. – Vol. 144. – P. 1280.

348. Duque M. C. Immunophenotyping of blood and cerebrospinal fluid leukocytes in dogs / M. C. Duque. – 2001. – 55 p.

172ЛИКВОР КАК ГУМОРАЛЬНАЯ СРЕДА ОРГАНИЗМА

349.Dynamic properties of lymphatic pathways for the absorption of cerebrospinal fluid / T. Brinker, W. Ledemann, D. Berens von Rautenfeld et al. // Acta Neuropathol. – 1997. – Vol 94. – P. 493–498.

350.Early neuropathological Alzheimer's changes in aged individuals are accompanied by decreased cerebrospinal fluid melatonin levels / Jiang–Ning Zhou, Rong–Yu Liu, Wouter Kamphorst et al. // Journal of Pineal Research. – 2003. – Vol. 35, № 2. – Р. 125–130.

351.Effects of physical activity and acupuncture on calcitonin gene–related peptide immunoreactivity in different parts of the rat brain

and in cerebrospinal fluid, serum and urine / Y. Wyon, M. Hammar, E. Theodorsson,КафедраT. Lundeberg // Acta Physiol Scand. – 1998. – Vol. 162, № 4. – P. 517–522.

352. Egashira Т. HTR2C Cys23Ser polymorphism in relation to

– 1999. – Vol. 46, № 6. – P. 821–826.

CSF monoamine metabolite concentrations and DSM–III–R psychiatric diagnosesнормальной/ Т. Egashira, F. Takayama, Y.Yamanaka // Biol. Psychiatry.

353. Egashira Т. Changes in monoamine metabolites concentrations

in rat cerebrospinal fluid after acute and long–term administration of a selective анатомииserotonin reuptake inhibitor, trazodone / Т. Egashira, Takayama F., Yamanaka Y. // Pharmacol Res. – 1999. – Vol. 40, № 6. – P. 503–508.

354. Elevated CSF prostaglandin E2 levels in patients with probable AD / T.J. Montine,КГМУK.R. Sidell, B.C. Crews et al. // Neurology.

– 1999. – Vol. 55, № 7. – P. 1495–1498.

355. Elevated interleukin–6 levels in cerebrospinal fluid of vascular dementia patients / K. Wada–Isoe, Y. Wakutani, K. Urakami, K. Nakashima // Acta Neurologica Scandinavica. – 2004. – Vol. 110, № 2.

– Р. 124–127.

356. Engelborghs S. Amino acids and biogenic amines in cerebrospinal fluid of patients with parkinson's disease / S. Engelborghs, Marescau В, Р.Р. De Deyn // Neurochemical Research. – 2003. – Vol. 28, № 8. – Р. 1145–1150.

357. Establishment and properties of neural stem cell clones: plasticity in vitro and in vivo / A.L. Vescovi, E.Y. Snyder // Brain Pathol. – 1999. – Vol. 9, № 3. – P.569 – 598.

358. Etude d’un liquide cephalo-rachidien artificiel / Lataste X., Vandendriessche M., Castel J.P., Cohadon F. //Neurochirurgie (Paris). – 1980. – Vol. 26, № 3. –Р. 201-220.

359. Evidence of connections between cerebrospinal fluid and nasal lymphatic vessels in humans, non–human primates and other mammalian species / M. Johnston, A. Zakharov, C. Papaiconomou et al. // Cerebrospinal fluid research. – 2004. – Vol. 1, №2. – P. 1 – 13.

360. Extraordinary changes in excitatory amino acid levels in cerebrospinal fluid of Influenza–associated encephalopathy of children /

H. Kawashima, T. Morishima, T. Togashi et al. // Neurochemical Research. – 2004Кафедра. – Vol. 29, № 8. – Р. 1537–1540.

361. Fabian R. H. Intraneuronal Ig G in the central nervous system / R. Н. Fabian, G. Petroff // Neurol. – 1987. – Vol.37, № 9. – P. 1780–1784.

362. Fabian R. H. Uptake of antineuronal Ig M by CNS neurons: comparisonнормальнойwith antineuronal Ig G / R. Н. Fabian // Neurol. – 1990. – Vol.40, № 5. – P. 419–422.

363. Filtration of cerebrospinal fluid for acute demyelinating

neuropathy in systemic lupus erythematosus / Stahl H.-D., Kalischewski P., Orda C. et alанатомии. //Clin Rheanimatol. – 2000. – Vol. 19 – Р. 61-63.

364. Filtration of cere-brospinal fluid in acute inflammatory demyelinating polyneuropathy (Guillain-Barre syndrome)/ Wollinsky K.H., Hulser P.J., Brinkmeier H. et al. // Ann Med Intern –1994. – Vol.145. –Р. 451-458. КГМУ

365. Finsterer J. Cerebrospinal fluid filtration in amyotrophic lateral sclerosis / Finsterer J., Mamoli В. // Eur J Neurol. – 1999. – Vol. 65. – Р. 597-600.

366. Finsterer J. Liquorpheresis (CSF filtration) in familial amyotrophic lateral sclerosis. / Finsterer J., Mamoli В.//Spinal Cord. – 1999. – Vol 37, №8. – Р.592-594.

367. Fliedner T.M. The stem cell system of hematopoiesis: physiological and pathophysiological concepts/ T.M. Fliedner, W.Nothdurft , W. Calvo //Verh Dtsch Ges Pathol.– 1990.–Vol. 74.–P.1–18.

368. Friede R. L. A new approach for determining the volume of cerebral extra–cellular fluid and demonstration of its communication with CSF / R.L. Friede, Kuo Hao Hu // J. Physiol. – 1971. – Vol. 218. – P. 477–493.

174ЛИКВОР КАК ГУМОРАЛЬНАЯ СРЕДА ОРГАНИЗМА

369.Gerner M. Altered neuropeptide concentrations in cerebrospinal fluid of psychiatric patient / М. Gerner, Yamada T. // Brain res. – 1982. – Vol. 238, № 1. – P. 298–302.

370.Gillette S. Changes in thymic estrogen receptor expression following orchidectomy / S. Gillette, R. Gillette // Cell Immunol. – 1979. – Vol. 42. –P. 194–196.

371.Gonadotropin–releasing hormone secretion into third–ventricle cerebrospinal fluid of cattle: correspondence with the tonic and surge release of luteinizing hormone and its tonic inhibition by suckling and

neuropeptide Y / O.S. Gazal, L.S. Leshin, R.L. Stanko et al. // Biol. Reprod. – 1998Кафедра. – Vol. 59, № 3. – P. 676–683.

372. Grimes M.A. Cerebrospinal fluid concentrations of tryptophan and 5–hydroxyindoleacetic acid in Macaca mulatta: diurnal variations

and response to chronic changes in dietary protein intake / М.А. Grimes, CameronнормальнойJ.L., Fernstrom J.D. // Neuro–chem Res. – 2000. – Vol. 25, № 3. – P. 413–422.

373. Guidelines on routine cerebrospinal fluid analysis. Report from

an EFNS task force / F. Deisenhammer, A. Bartos, R. Egg et al. // European Journalанатомииof Neurology. – 2006. – Vol. 13. – P. 913–922.

374. Hefco V. The modulator role of the hypothalamic paraventricular nucleus of immune responsiveness / Hefco V., Olariu V. A., А. Hevko // Brain Behav. Immunol. – 2004. – Vol. 18, № 2. – P.

375.HeldermanКГМУJ.H. Specific insulin binding site on T and B lymphocytes as a marker of cell activation / J.H. Helderman, T. Strom // Nature. – 1978. – Vol. 274. – P. 62–63.

376.Hepatocyte growth factor in cerebrospinal fluid in neurologic disease / Y. Tsuboi, K. Kakimoto, H. Akatsu et al. // Acta Neurologica Scandinavica. – 2002. – Vol. 106, № 2. – Р. 99–103.

377.Hepatocyte growth factor levels in cerebrospinal fluid: a comparison between fcute bacterial and nonbacterial meningitis / F. Nayeri, I. Nilsson, L. Hagberg et al. // J. Infect. Dis. – 2000. – Vol. 181,

№6. – P. 2092–2094.

378.Herring P. The histological appearances of the mammalian pituitary body / Р. Herring // Quart. J. Experim. Phisiol. - 1908. – Vol. 1,

№5 – P. 121–159.

379. Hiesland P. Mechanism of action: cyclosporin and prolactin– mediated control of immunity / P. Hiesland, P. Mekler // Prog. Allergy.

– 1986. – Vol. 38. – P. 239–246.

380. Hirai K. Cerebrospinal fluid somatostatin levels in febrile seizure and epilepsy in children / К. Hirai, Т. Seki // Neuropeptides. – 2000. – Vol. 34, № 1. – P. 18–24.

381. Hoff H. Untersuchungen uber die Becinflussung der Pituitrinsecretion durch Diuretica / Н. Hoff, Р. Wermer // Klin. Wochenschr. – 1927. – № 5. – S. 25.

382. Holienberg M.D. Hormone receptors and membrane glycoproteins duringКафедраin vitro transformation of lymphocytes / Holienberg M.D., Р. Cuatrecasa –New York: Cold Spring Harbor Laboratory, 1974. – Р.423–434 .

383. Hulser P.J. Liquorpheresis eliminates blocking factors from cerebrospinalнормальнойfluid in polyradiculoneuritis (Guillain-Barre syndrome) / Hulser P.J., Wietholter H., Wollinsky K.H. // Eur Arch Psychiat Clin

Neurosci . –1991. –Vol. 241, № 2. –Р.69-72.

384.Human cerebrospinal fluid contains CD4+ memory T cells expressing gutанатомии– or skin–specific trafficking determinants: relevance for immunotherapy / P. Kivisakk, B. Tucky, T. Wei et al. // BMC Immunology. – 2006. – Vol. 7, № 14. – P. 1–8.

385.Human chorionic gonadotrophin in CSF, not serum, predicts outcome in germinoma /КГМУТ. Inamura, S. Nishio, K. Ikezaki, M. Fukui // J. Neurol. Neurosurg. Psychiatry. – 1999. – Vol. 66, № 5. – P. 654–657.

386.Identification of beta–adrenoceptors during thymocyte ontogeny in mice / U. Singh, D.S. Millson, P.A. Smith et al. // Eur J lmmunol. – 1979. – Vol. 9. – P. 31–35.

387.IgM quantification in the cerebrospinal fluid of sleeping sickness patients by a latex card agglutination test / V. Lejon, D. Legros, M. Richer et al. // Tropical Medicine & International Health. – 2002. – Vol. 7, № 8. – Р. 685–692.

388.Ilzecka J. Brain–derived neurotrophic factor is not altered in the serum and cerebrospinal fluid of amyotrophic lateral sclerosis patients / Ilzecka J., Stelmasiak Z. // Neurological Sciences. – 2002. – Vol. 22, № 6. – Р. 473–474.

389.In situ histochemical localization of type I interleukin–1

receptor messenger RNA in the central nervous system, pituitary, and adrenal gland of the mouse /E.T. Cunningham, E. Wada, D.B. Carter et al. // J. Neurosci. – 1992. – Vol.12. – P. 1101–1114.

390.In vitro studies of immunoregulation by substance P and somatostatin /A. Stanisz, R. Scicchitano, D. Payan et al. // Ann N Y Acad Sci. – 1987. – Vol. 496. – P. 217–225.

391.Increased cerebrospinal fluid cAMP levels in Alzheimer's disease / M. Martinez, E. Fernandez, A. Frank et al. // Brain Res. – 1999.

–Vol. 846, № 2. – P. 265–267.

392.Increased hepatocyte growth factor level in cerebrospinal fluid in Alzheimer'sКафедраdisease / Y. Tsuboi, K. Kakimoto, M. Nakajima et al. // Acta Neurologica Scandinavica. – 2003. – Vol. 107, № 2. – Р. 81–86.

393.Increased levels of TRH in cerebrospinal fluid from patients

with endogenous depression / С. Kirkergaard, Faber J., Hummer L., Р. RogowsciнормальнойP. // Psychoneuroendocrinology. – 1979. – Vol. 4, №3. – P. 227–235.

394. Influence of CSF filtration on a new gliotoxic factor in

cerebrospinal fluid from multiple sclerosis patients / Т. Dobransky, Amouri R.анатомии, Wollinsky K.H. et al. // Neuropsychiatrie. – 1995. –Vol. 9. – Р. 89-93.

395. Insulin–like growth factor binding proteins in cerebrospinal fluid during human development and aging / P. M. Arnold, J.Y. Ma, B.A. Citron, B.W. FestoffКГМУ// Biochem. Biophys. Res. Commun. – 1999.

– Vol. 264, № 3. – P. 652–656.

396. Interaction of glucocorticoids with macrophages. Indentification of glucocorticoid receptors in monocytes and macrophages / Z. Werb, R. Foley, A. Munck et al. // J. Exp Med. – 1978.

– Vol. 147. – P. 1684–1694.

397. Interactions among CNS, neuroendocrine and immune systems / R.M.A. Landmann, M. Wesp, R. Box. – Rome: Pythagora Press, 1989.

– P. 251–264.

398. Intracerebroventricular but not intravenous interleukin–1b induces widespread vascular–mediated leukocyte infiltration and immune signal mRNA expression followed by brain–wide glial activation / M.G. Proescholdt, S. Chakravarty, J. A. Foster et al. // Neuroscience. – 2002. – Vol. 112, № 3. – Р. 731–749.

399.Intrathecal adenosine analog administration reduces substance P in cerebrospinal fluid along with behavioral effects that suggest antinociception in rats / K.F. Sjolund, A. Sollevi, M. Segerdahl, T. Lundeberg // Anesth Analg. – 1997. – Vol. 85, № 3. – P. 627–632.

400.Intrathecal IgG synthesis: marker of progression in multiple sclerosis patients / G. Izquierdo, S. Angulo, J.M. Garcia–Moreno et al. // Acta Neurologica Scandinavica. – 2002. – Vol. 105, № 3. – Р. 158–163.

401.Investigation of cytokine (tumor necrosis factor–alpha, interleukin–6, interleukin–10) concentrations in the cerebrospinal fluid

of female patients with multiple sclerosis and systemic lupus erythematosus /КафедраK. Baraczka, K. Nekam, T. Pozsonyi et al. // European Journal of Neurology. – 2004. – Vol. 11, № 1. – Р. 37–42.

402. Johnston M. Possible role of the cavernous sinus veins in

cerebrospinal fluid absorption / M. Johnston, D. Armstrong, L. Koh // Cerebrospinalнормальнойfluid research. – 2007. – Vol. 4, №3. – P. 1 – 5.

403. Joseph S. Releasing hormones, LRF and TRF in the cerebrospinal fluid of the third ventricle / Joseph S., Sorrentino S.,

Sundberg D. // Brain–Endocrine Interaction. II. The ventricular system.

– 2nd internat. symposанатомии. –Shizuoka, 1974, Basel, 1975. – P. 306–312. 404. Kabayashi H. Absorption of cerebrospinal fluid by ependimal

cells of the median eminence / Kabayashi H. // Brain–Endocrine Interaction. II. The ventricular system. –2nd internat. sympos. –Shizuoka, 1974, Basel, 1975. – P. 109КГМУ–122.

405. Kalin N.H. Cerebrospinal fluid corticotropin–releasing hormone levels are elevated in monkeys with patterns of brain activity associated with fearful temperament / Kalin N.H., S.Е. Shelton, Davidson R.J. // Biol. Psychiatry. – 2000. – Vol. 47, № 7. – P. 579–585.

406. Kamberi J.A. Effecys of melatonin and serotonin on the release of FSH and prolactin / Kamberi J.A., Mical R.S., Porter J. // Endocrinology. – 1971. – Vol. 88, № 6. – P. 1288–1293.

407. Karplus J. Ueber die Beeinflussung der Hypophysentatigkeit durch die Erregung des Hypothalamus / Karplus J., О. Peczenik // Pflugers Arch. – 1930. – Bd. 225. – S. 654–668.

408. Kauers U. The diagnostic validity of lysozyme activity in lumbal Cerebrospinal fluid and in serum / Kauers U., В. Weisner // J. Clin. and Clin. Biochem. – 1981. – Vol. 19, № 8. – P. 726–727.

178ЛИКВОР КАК ГУМОРАЛЬНАЯ СРЕДА ОРГАНИЗМА

409.Kendall J. Etudes on the transport of hormones from the cerebrospinal fluid to hypothalamus and pituitary / Kendall J., Jacobs I., R. Kramer // Brain–Endocrine Interaction., Basel, 1972. – P. 342–349.

410.Kirschfink M., Rother S. CSF-filtration a new therapeutical concept /// Anaesthesia, Pain, Intensive Care and Emergency Medicine, A. Gullo (eds). –Milano, 1994. – Р.577-586.

411.Kjellin T. Der gehal an Prolan in Liquor cerebrospinalis besonders bei eccentieller Hypertonie /Т. Kjellin, Е. Kylin Е. // Deutsches Archfur Klinische medicin. – 1934. – Vol. 176, № 6. – Р.

683–689.

(CSF) /Т.О. Kleine, Т. Damm Т. // Analytical and Bioanalytical

412. KleineКафедраT.O. Molecular heterogeneity, detected by two electrophoretic micro procedures, of IgG in human cerebrospinal fluid

Chemistry. – 2003. – Vol. 375, № 8. – Р. 1000–1005. 413нормальной. Knowles F. Cerebrospinal fluid and endocrine regulation /

Knowles F. // Proc. internat. Sympos. – Bratislava, 1974. – P. 11–28. 414. Konagaya Y. Abnormality of hypothalamic dopaminergic

system in neuro–degenerative diseases–evaluation of alpha– melanocyteанатомии–stimulating hormone–like immunoreactivity in Cerebrospinal fluid / Konagaya Y., М. Konagaya // Rinsho Shinkeigaku.

– 1991. – Vol. 31, № 8. – P. 821–825.

415. Kontinuierliche liquorfiltration bei foudroyanter bakterieller meningitis / KalischewskiКГМУP., Berrouschot J., Kohn H.-J. et al. //Akta Neurol. –1996. –Vol. 23. –Р. 61.

416. Kordon C. Role of neurotransmitters in the secretion of pituitary gonadotropins and prolactin / С. Kordon C. //Control of ovulation. – London, 1978. – P. 21–28.

417. Kratochvil A. Correlations Between the cerebrospinal fluid surface tension value and 1. Concentration of total proteins 2. Number of cell elements / А. Kratochvil, Е. Hrncir E. // Gen. Phisiol. And Biophis. – 2002. – Vol. 21, № 1. – P. 47–53.

418. Krubitzer L. Nature versus nurture revisited: an old idea with a new twist / L. Krubitzer, D. M. Kahn // Prog Neurobiol. – 2003. – Vol. 70. – P. 33–52.

419. Kwon C.H. Pten regulates neuronal arborization and social interaction in mice / С.Н. Kwon // Neuron. – 2006. – vol. 50. – P. 377–388.

420.Lack of correlation between cerebrospinal fluid thyrotropin– releasing hormone (TRH) and TRH–stimulated thyroid–stimulating hormone in patients with depression / M.A. Frye, R.T. Dunn, K.A. Gary et al. // Biol Psychiatry. – 1999. – Vol. 45, № 8. – P. 1049–1052.

421.Landt M. Leptin in cerebrospinal Fluid from children: correlation with plasma leptin, sexual dimorphism, and lack of protein binding / М. Landt, Parvin C.A., М. Wong M. // Clin. Chem. – 2000. – Vol. 46, № 6. – P. 854–858.

422.Lefvert A.KIg G production with the central nervous system, a

critical review of proposed formulae / А.К. Lefvert, Link H. // Ann. neurol. – 1984. –КафедраVol.16, № 5. – P. 13–20.

423. Liquorpherese – ein neuer ansatz in der therapie des GuillainBarre syndroms / Hulser P.J., Wollinsky K.H., Weindler M. et al. //Verh

Dtsch Ges Neurol. –1990. –Vol. 6. –Р. 620-621. 424.нормальнойLiquorpherese bei 10 patienten mit multipler skleros ./

Wollinsky K.H., Hulser P.J., Mauch E. et al. // Verb Dtsch Ges Neurol. –1992. –Vol. 7. –Р. 444-445.

425.Liquor-pheresis (CSF-Filtration) an effective treatment in acute and chronicанатомииsevere autoimmune polyradiculoneuritis (GuillainBarre syndrome)/ Wollinsky K.H., Weindler M., Hulser P.J. et al. // Eur Arch Psych Clin Neurosci. – 1991. –Vol. 241. – Р. 73-76.

426.Liu Guo–qing. Zhang Xiao–rong. Zhao You–zhang // Zhongswo shouyi xuebaoКГМУ= Chin. J. Vet. Sci. – 2002. – Vol. 22. № 3. – С. 265–266.

427.Liu Z. A high–recovery extraction procedure for quantitative analysis of substance P and opioid peptides in human cerebrospinal fluid

/Liu Z., М. Welin, Bragee B. F. // Nyberg Peptides. – 2000. – Vol. 21, № 6. – P. 853–860.

428.Low calcitonin gene–related, peptide–like immunoreactivity in cerebrospinal fluid from chronic pain patients / C. Lindh, Z. Liu, M. Welin et al. // Neuropeptides. – 1999. – Vol. 33, № 6. – P. 517–521.

429.Luteinizing hormone (LH)–releasing hormone in third ventricular cerebrospinal fluid of the ewe: correlation with LH pulses and the LH surge / D.C. Skinner, В. Malpaux, В. Delaleu, A. Caraty // Endocrinology. – 1995. – Vol. 136, № 8. – P. 3230–3237.

430. Lymphocyte blast transformation. Demonstration of adrenergic receptors in human peripheral lymphocytes / J.W. Hadden, E.M. Hadden, E.J. Middleton et al. // Cell Immunol. – 1970. – Vol. 1. – P. 583–595.

431. Lyson K. The effect of interleukin–6 on pituitary hormone release in vivo and in vitro / К. Lyson K., S.М. McCann // Neuroendocrinology. – 1991. – Vol. 54. – P. 262–266.

432. Macrophages and neurodegeneration / J.J. Hendriks, C.E. Teunissen, H.E. Vries et al. // Brain Res Brain Res Rev. – 2005. – Vol.

48. – P. 185–195.

433. ManfrediКафедраP.L. CSF filtration is an effective treatment of Guillain-Barre syndrome A randomized clinical trial / Manfredi P.L.

//Neurology. – 2002. – Vol 58. – Р. 988–989.

434. Marquette C. IL–1 beta, TNF alpha and IL–6 inductions in the rat brainнормальнойafter portal–body irradiation: role of vagal afferents / С. Marquette // Int. J. Radiat. Biol. – 2003. – Vol. 79, № 10. – P. 777–785.

435. Martin S.B. Tumor necrosus factor a (TNF) in

neuroimmunology / S.В. Martin, Tracey K.J. // Adv Neuroimmunol. – 1992. – Volанатомии. 2. – P. 125–138.

436. Martinez M. Changes cerebrospinal fluid cAMP levels in Alzheimer's disease patients / М. Martinez // Brain Res. – 1998. – Vol. 834, № 2. – P. 223–242.

437. MeasuringКГМУHIV–1 RNA and interferon–alpha in the cerebrospinal fluid of AIDS patients: insights into the pathogenesis of AIDS Dementia Complex / A. Krivine, G. Force, J. Servan et al. // J. Neurovirol. – 1999. – Vol. 5, № 5. – P. 500 – 506.

438. Melrose Patricia Ann. Anatomical and hormonal studies investigating a possible role for cerebrospinal fluid in neuroendocrine communication associated with the control of reproduction (horse) / Melrose Patricia Ann //Dissertation Abstracts International. – 1984. – Vol. 44, № 6. – P. 1742.

439. Mess B. Effects of intracerebral serotonin administration on the function of the thyrotrophic hormone (TSH) – thyreoid system / В. Mess, Peter L. // Endocrinol. Exp. – Vol. 8, № 3. – P. 160–168.